Bangalore, India -- (SBWire) -- 06/07/2017 --The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.
Report forecast the global bladder cancer therapeutics market to grow at a CAGR of 4.77% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global bladder cancer therapeutics market for 2017-2021. To calculate the market size, the report considers the sales from both branded and generic drugs.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Global Bladder Cancer Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Bristol-Myers Squibb
- Eli Lilly
- F. Hoffman-La Roche
- Pfizer
Other prominent vendors
- Accord Healthcare
- AstraZeneca
- Bedford Lab
- Merck
- Sanofi
Market driver
- Growing prevalence rate leads to higher prescription value
- For a full, detailed list, view our report
Market challenge
- Economic burden of bladder cancer
- For a full, detailed list, view our report
Market trend
- Advent of novel pipeline
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 70 pages "Global Bladder Cancer Therapeutics Market 2017-2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market segmentation by therapy, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.
For more information Visit at: http://www.drugpipeline.net/technavio/global-bladder-cancer-therapeutics-market-2017-2021
Find all Oncology Reports at - http://www.drugpipeline.net/catalog/oncology
About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.
Global Bladder Cancer Therapeutics Market 2017-2021; New Report Launched
DrugPipeline.net has announced the addition of “Global Bladder Cancer Therapeutics Market 2017-2021” research report to their website www.DrugPipeline.net